<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-01774R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0001132</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Dermatology</subject><subject>Cell Biology/Cell Adhesion</subject><subject>Cell Biology/Cell Signaling</subject><subject>Cell Biology/Leukocyte Signaling and Gene Expression</subject><subject>Immunology/Innate Immunity</subject><subject>Immunology/Leukocyte Activation</subject><subject>Physiology/Cell Signaling</subject></subj-group></article-categories><title-group><article-title>Syk-Mediated Translocation of PI3K&#x003b4; to the Leading Edge Controls Lamellipodium Formation and Migration of Leukocytes</article-title><alt-title alt-title-type="running-head">Syk Controls PI3K&#x003b4; in PMN</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Schymeinsky</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Then</surname><given-names>Cornelia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sindrilaru</surname><given-names>Anca</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gerstl</surname><given-names>Ronald</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jakus</surname><given-names>Zolt&#x000e1;n</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tybulewicz</surname><given-names>Victor L. J.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scharffetter-Kochanek</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Walzog</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Physiology, Ludwig-Maximilians-University Munich, Munich, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Division of Immune Cell Biology, National Institute for Medical Research, London, United Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Gay</surname><given-names>Nick</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Cambridge, United Kingdom</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>walzog@lrz.uni-muenchen.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: KS JS BW AS. Performed the experiments: JS CT AS. Analyzed the data: KS JS BW CT AS. Contributed reagents/materials/analysis tools: VT RG ZJ. Wrote the paper: JS BW.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>7</day><month>11</month><year>2007</year></pub-date><volume>2</volume><issue>11</issue><elocation-id>e1132</elocation-id><history><date date-type="received"><day>16</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>10</day><month>10</month><year>2007</year></date></history><copyright-statement>Schymeinsky et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><p>The non-receptor tyrosine kinase Syk is mainly expressed in the hematopoietic system and plays an essential role in &#x003b2;<sub>2</sub> integrin-mediated leukocyte activation. To elucidate the signaling pathway downstream of Syk during &#x003b2;<sub>2</sub> integrin (CD11/CD18)-mediated migration and extravasation of polymorphonuclear neutrophils (PMN), we generated neutrophil-like differentiated HL-60 (dHL-60) cells expressing a fluorescently tagged Syk mutant lacking the tyrosine residue at the position 323 (Syk-Tyr<sup>323</sup>) that is known to be required for the binding of the regulatory subunit p85 of the phosphatidylinositol 3-kinase (PI3K) class I<sub>A</sub>. Syk-Tyr<sup>323</sup> was found to be critical for the enrichment of the catalytic subunit p110&#x003b4; of PI3K class I<sub>A</sub> as well as for the generation of PI3K products at the leading edge of the majority of polarized cells. In accordance, the translocation of PI3K p110&#x003b4; to the leading edge was diminished in Syk deficient murine PMN. Moreover, the expression of EGFP-Syk Y323F interfered with proper cell polarization and it impaired efficient migration of dHL-60 cells. In agreement with a major role of &#x003b2;<sub>2</sub> integrins in the recruitment of phagocytic cells to sites of lesion, mice with a Syk-deficient hematopoietic system demonstrated impaired PMN infiltration into the wounded tissue that was associated with prolonged cutaneous wound healing. These data imply a novel role of Syk via PI3K p110&#x003b4; signaling for &#x003b2;<sub>2</sub> integrin-mediated migration which is a prerequisite for efficient PMN recruitment in vivo.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The efficient recruitment of polymorphonuclear neutrophils (PMN) to sites of lesion is critical for host defense, inflammation and tissue repair <xref ref-type="bibr" rid="pone.0001132-Nathan1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Eming1">&#x0005b;2&#x0005d;</xref>. An essential step during this process is chemotactic migration which requires the presence of chemoattractants and depends on adhesive cell-matrix interactions that are mainly mediated by the leukocyte adhesion molecules of the integrin family <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Anderson1">&#x0005b;4&#x0005d;</xref>. Especially, &#x003b2;<sub>2</sub> integrins (CD11/CD18) are critically involved in firm adhesion and migration of PMN <xref ref-type="bibr" rid="pone.0001132-Anderson1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Hynes1">&#x0005b;5&#x0005d;</xref>. The &#x003b2;<sub>2</sub> integrins are heterodimers consisting of a common &#x003b2;-subunit (CD18) which is non-covalently associated with one of the four known &#x003b1;-subunits (CD11) and are named accordingly: CD11a/CD18 (&#x003b1;L&#x003b2;<sub>2</sub>, LFA-1), CD11b/CD18 (&#x003b1;M&#x003b2;<sub>2</sub>, Mac-1, CR3), CD11c/CD18 (&#x003b1;X&#x003b2;<sub>2</sub>, gp150/95, CR4) or CD11d/CD18 (&#x003b1;D&#x003b2;<sub>2</sub>) <xref ref-type="bibr" rid="pone.0001132-Hynes1">&#x0005b;5&#x0005d;</xref>. The pivotal role of CD18 during the acute inflammatory response becomes obvious in patients suffering from leukocyte adhesion deficiency type-1 (LAD-1) where a defective CD18 expression is the cause of impaired wound healing and recurrent bacterial infections due to a recruitment defect of PMN <xref ref-type="bibr" rid="pone.0001132-Anderson1">&#x0005b;4&#x0005d;</xref>. Accordingly, a recent in vivo study demonstrated an impaired adhesion of LFA-1<sup>&#x02212;/&#x02212;</sup> PMN to the wall of postcapillary venules of the murine cremaster muscle upon stimulation with macrophage inflammatory protein-2 (Mip-2) and a decreased intraluminal crawling of Mac-1<sup>-/-</sup> PNM accompanied by a delayed emigration through nonoptimal sites <xref ref-type="bibr" rid="pone.0001132-Phillipson1">&#x0005b;6&#x0005d;</xref>. Downstream signaling of CD18 via specific Immunoreceptor Tyrosine-based Activation Motif (ITAM)-bearing adapter proteins (i.e. DAP12 and the Fc receptor (FcR) &#x003b3;-chain) leads to the activation of the non-receptor tyrosine kinase Syk <xref ref-type="bibr" rid="pone.0001132-Mcsai1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001132-Mcsai2">&#x0005b;9&#x0005d;</xref> which has been shown to be critical for migration of neutrophil-like differentiated HL-60 cells (dHL-60) and primary murine PMN <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Schymeinsky2">&#x0005b;11&#x0005d;</xref>. Syk has several interacting signaling partners e.g. Vav, the phophoinositide-specific phospholipase C (PLC) isozymes PLC&#x003b3;-1 and PLC&#x003b3;-2, and Cbl which are known to exert a functional impact on different leukocyte functions including cell migration <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001132-Caveggion1">&#x0005b;17&#x0005d;</xref>. Recently, a direct interaction between Syk and the regulatory subunit p85 of the phosphatidylinositol 3-kinases (PI3K) class I<sub>A</sub> has been demonstrated <xref ref-type="bibr" rid="pone.0001132-Groesch1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Moon1">&#x0005b;18&#x0005d;</xref>.</p><p>PI3Ks are grouped into three classes, I, II and III, according to their substrate preference and structural homology <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>. Class I PI3Ks, which produce the secondary messenger phosphatidylinositol-(3,4,5)-trisphosphate (PIP3), are divided into two subgroups, I<sub>A</sub> and I<sub>B</sub>. Class I<sub>A</sub> PI3Ks are tightly bound heterodimers that consists of a p50&#x02013;55/p85 regulatory subunit and one of the three p110 catalytic subunits, p110&#x003b1;, p110&#x003b2; or p110&#x003b4;. The three isoforms of the p85 regulatory subunit (p85&#x003b1; with its splice products p55&#x003b1; and p50&#x003b1;, p85&#x003b2; and p55&#x003b3;) mediate the activation of class I<sub>A</sub> PI3K by binding to receptor tyrosine kinases and adaptor molecules. This binding relieves the basal inhibition of p110 by p85 and recruits the p85&#x02013;p110 heterodimer to its substrate at the plasma membrane. Class I<sub>B</sub> PI3Ks are dimers consisting of the catalytic subunit p110&#x003b3; and one of the regulatory subunits p101 or p84 (p87<sup>PIKAP</sup>) <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Hawkins1">&#x0005b;20&#x0005d;</xref>. The PI3K signaling pathway is critically involved in the control of PMN motility and chemotaxis <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref> and &#x003b2;<sub>2</sub> integrins are capable of activating PI3K in PMN <xref ref-type="bibr" rid="pone.0001132-Axelsson1">&#x0005b;21&#x0005d;</xref>. In these cells, chemoattractants can activate both the class I<sub>A</sub> PI3K as well as the class I<sub>B</sub> PI3K, i.e. p110&#x003b3; which is regulated by G-protein coupled receptor signaling <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Wettschureck1">&#x0005b;22&#x0005d;</xref>. Furthermore, a relevance of Syk in the activation of PI3K has been described for T cell and B cell receptor-mediated signaling and in PMN after the stimulation with monosodium urate crystals <xref ref-type="bibr" rid="pone.0001132-vonWillebrand1">&#x0005b;23&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001132-PopaNita1">&#x0005b;25&#x0005d;</xref>.</p><p>In the present study, we unraveled the physiological role of Syk-mediated translocation and activation of PI3K p110&#x003b4; upon adhesion and polarization of leukocytes in the presence of the &#x003b2;<sub>2</sub> integrin ligand fibrinogen. Cell polarization and migration of dHL-60 cells expressing fluorescently tagged wildtype Syk and a Syk mutant lacking the binding site for the p85 regulatory subunit of PI3K Class I<sub>A</sub> (EGFP-Syk Y323F, mCherry-Syk Y323F) were analyzed in vitro by confocal microscopy and time-lapse video microscopy. To address the in vivo relevance of Syk-mediated signaling for PMN recruitment to sites of lesion, we performed a wound healing assay using wildtype mice reconstituted with a Syk deficient hematopoietic system.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Reagents and antibodies</title><p>BSA, human fibrinogen, fMLP and Percoll<sup>TM</sup> were obtained from Sigma, Deisenhofen, Germany. Piceatannol was obtained from Calbiochem, La Jolla, CA, USA. We purchased RPMI 1640 medium, FCS, penicillin, streptomycin and PBS from Biochrom, Berlin, Germany. IMDM including L-Glutamine and 25 mM HEPES was purchased from Invitrogen, Karlsruhe, Germany. Antibodies to Syk (clone 4D10, IgG<sub>2a</sub>), p110&#x003b4; (H-219, sc-7176), p110&#x003b3; (H-199, sc-7177), Cbl (C-15, sc-170), PLC&#x003b3;-1 (2R1, sc-58408), PLC&#x003b3;-2 (B-10, sc-5283), or Dock2 (E-15, sc-50921) were obtained from Santa Cruz, Santa Cruz, CA, USA. The monoclonal anti-CD18 antibody (clone MHM23) was purchased from DakoCytomation, Glostrup, Denmark. Alexa fluorochrome-conjugated secondary antibodies and phalloidin were purchased from Invitrogen, Karlsruhe, Germany.</p></sec><sec id="s2b"><title>cDNA contructs</title><p>The EGFP-tagged Syk Y323F mutant was obtained from the non-mutated EGFP-Syk plasmid as described previously <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. The used DNA oligonucleotides 5&#x02032;-TGTCATTCAATCCGTTT-GAGCCAGAACTTGG-3&#x02032; and its complement reverse form were obtained from Metabion, Martinsried, Germany. The introduction of the expected mutation was confirmed by automated DNA sequencing (Medigenomix, Martinsried, Germany). For the expression of red fluorescent fusion proteins the coding region of EGFP of the EGFP-C1 expressing vector (Clontech, BD New York, USA) was replaced with a PCR-DNA Fragment of the mCherry cDNA flanked with a NheI and a BglII restriction site (DNA oligonucleotides: forward 5&#x02032;-GCTAGCGCCACCATGGTGAGC-AAGGGCGAG-3&#x02032;, and reverse 5&#x02032;-CTGACAGATCTCTTGTACAGCTCGTCCATGC-3&#x02032;). The mCherry cDNA was a generous gift of Dr. Roger Y. Tsien, Dept. of Chemistry and Biochemistry, University of California at San Diego, La Jolla, CA, USA <xref ref-type="bibr" rid="pone.0001132-Shaner1">&#x0005b;26&#x0005d;</xref>. The coding region of wildtype Syk or Syk Y323F was cloned into the <italic>EcoR</italic>I/<italic>Kpn</italic>I site of the newly synthesized mCherry-C1 vector.</p></sec><sec id="s2c"><title>Cell culture and electroporation of dHL-60 cells</title><p>The human myeloid HL-60 cell line (ACC 3) was obtained from the German Resource Centre for Biological Material (Braunschweig, Germany). The HL-60 cell line stably expressing PH-AKT-GFP was kindly provided by Dr. H. R. Bourne, UCSF, CA, USA <xref ref-type="bibr" rid="pone.0001132-Servant1">&#x0005b;27&#x0005d;</xref>. PMN-like differentiation of HL-60 cells and the electroporation protocol was described previously <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. The generation of the HL-60 cell line stably expressing a Syk specific short hairpin RNA which led to a reduced Syk expression via the generation of short interfering RNA (Syk-siRNA) was generated as described <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>.</p></sec><sec id="s2d"><title>Isolation of murine bone marrow PMN</title><p>Murine bone marrow PMN were isolated as described previously <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. Briefly, the bone marrow from femurs and tibias was isolated and subsequently loaded on top of a discontinuous Percoll&#x02122; gradient (52&#x00025;/64&#x00025;/72&#x00025;) and centrifuged at 1000 g for 30 min. PMN were harvested from the 64&#x00025;/72&#x00025; interface and cultivated for 24 h in RPMI 1640 medium supplemented with 20&#x00025; of WEHI-3B-conditioned medium. PMN viability was &#x0003e;95&#x00025; as assessed by the trypan blue exclusion test, purity was &#x0003e;98&#x00025; as analyzed by microscopy using Hemacolor&#x02122; staining (Merck, Darmstadt, Germany).</p></sec><sec id="s2e"><title>Functional assays and microscopy</title><p>Adhesion and migration assays and time-lapse video microscopy was performed as described previously. Polarized dHL-60 cells were prepared for staining and used for confocal microscopy as described <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>.</p></sec><sec id="s2f"><title>Wound-healing model</title><p>The wound healing assay was performed as described <xref ref-type="bibr" rid="pone.0001132-Peters1">&#x0005b;28&#x0005d;</xref>. Briefly, after anaesthetizing the mice, excisional wounds were punched at four sites in the middle of the dorsum using 5-mm biopsy stamps (STIEFEL, Offenbach, Germany). Each wound region was digitally photographed at indicated time points, and areas were calculated using photoshop software (Adobe Systems, San Jose, CA, USA). For immunohistochemistry wound granulation tissues were fixed in 4&#x00025; neutral buffered formalin and embedded in paraffin. Neutrophils were detected using an anti-Gr-1 antibody (clone RB6-8C5, BD Pharmingen, Heidelberg, Germany) as described <xref ref-type="bibr" rid="pone.0001132-Peters1">&#x0005b;28&#x0005d;</xref>. Slides were visualized using a Zeiss Axiophot microscope (Carl Zeiss Inc., Oberkochen, Germany) and pictures were acquired with a digital color camera and corresponding software (Axiocam&#x000ae;, Zeiss). Mice carrying the Syk<sup>tm1Tyb</sup> (referred to as Syk<sup>&#x02212;</sup>) mutation were maintained as Syk<sup>&#x0002b;/&#x02212;</sup> heterozygotes on the C57BL/6 genetic background <xref ref-type="bibr" rid="pone.0001132-Turner1">&#x0005b;29&#x0005d;</xref>. The generation of mice with a Syk<sup>&#x02212;/&#x02212;</sup> hematopoietic system was performed as described previously <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>.</p></sec><sec id="s2g"><title>Statistical analysis</title><p>Data shown represent means&#x000b1;SD. Statistical significance was determined using a two-tailed Student's <italic>t</italic>-test or the Mann-Whitney U-test, in case of non-normal distributions. p&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Syk-Tyr<sup>323</sup> is required for the consolidation of the leading edge and for efficient migration of dHL-60 cells</title><p>To characterize the CD18-mediated signaling pathway downstream of Syk during PMN migration and infiltration, we generated dHL-60 cells transiently expressing an EGFP-tagged Syk mutant (EGFP-Syk Y323F), where the major binding site of the regulatory subunit p85 of the PI3K class I<sub>A</sub> was removed <xref ref-type="bibr" rid="pone.0001132-Groesch1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Moon1">&#x0005b;18&#x0005d;</xref>. As expected, EGFP-Syk expressing cells polarized upon stimulation by 100 nM fMLP on immobilized fibrinogen and the majority of these cells formed one lamellipodium that was characterized by an enrichment of F-actin and CD18. However, 29.7&#x00025; of the cells formed more than one lamellipodium (<xref ref-type="fig" rid="pone-0001132-g001">Figure 1A and C</xref>). In contrast, 51.8&#x00025; of the EGFP-Syk Y323F expressing cells showed an excessive lamellipodium formation, whereas CD18 was still enriched at the leading edge. Furthermore, dHL-60 cells expressing EGFP-Syk enriched Syk at the lamellipodium (63.4&#x00025;) which is in accordance with our previous findings (<xref ref-type="fig" rid="pone-0001132-g001">Figure 1B and D</xref>) <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. Similarly, 66.0&#x00025; of the Syk Y323F mutants showed an enhanced EGFP fluorescence at the lamellipodium indicating that Syk-Tyr<sup>323</sup> was not required for the translocation of Syk but involved in the consolidation of the leading edge. As the establishment of ordered cell polarity is a prerequisite for efficient cell migration, we performed migration assays using dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F. Whereas 87.4&#x00025; of the EGFP-Syk transfectants performed efficient migration on immobilized fibrinogen along a gradient of 10 nM fMLP (<xref ref-type="fig" rid="pone-0001132-g001">Figure 1E and F</xref>), this percentage was significantly reduced to 39.5&#x00025; in cells expressing the Syk mutant which again formed multiple and unstable lamellipodia (Please see also <xref ref-type="supplementary-material" rid="pone.0001132.s002">Movie S1</xref> and <xref ref-type="supplementary-material" rid="pone.0001132.s003">Movie S2</xref> presented as supplemental information). These results indicate that Syk-Tyr<sup>323</sup> supported the maintenance of cell polarity, a prerequisite for efficient cell migration suggesting that the PI3K class I<sub>A</sub> may act downstream of Syk.</p><fig id="pone-0001132-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g001</object-id><label>Figure 1</label><caption><title>Syk-Tyr<sup>323</sup> was required for the consolidation of the leading edge during CD18-mediated migration of dHL-60 cells.</title><p>(A,B) Confocal microscopy images of dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F stained for CD18 (A) or F-actin (B). Upon stimulation by 100 nM fMLP on immobilized fibrinogen, all transfectants polarized and formed lamellipodia (black arrows and arrow heads), which were characterized by an enrichment of CD18, F-actin, EGFP-Syk, or EGFP-Syk Y323 (white arrows and arrow heads). However, the expression of the Syk mutant led to the formation of multiple lamellipodia (arrow heads). Pictures are representative of at least three independent experiments. Quantitative analysis of microscopic images of fixed dHL-60 cells showing the percentage of cells with (C) excessive lamellipodium formation and (D) enhanced EGFP epifluorescence at the lamellipodium (n&#x0003e;300 cells each, taken from at least three independent experiments). (E) Time-lapse microscopy of migrating dHL-60 transfectants on immobilized fibrinogen in response to a gradient of 10 nM fMLP (&#x025b4;). Images 1&#x02013;5 were recorded at intervals of 30 s. Control transfectants migrated efficiently in contrast to Syk Y323F mutants which formed multiple, unstable lamellipodia and showed impaired migration. The outlines of the cells at intervals of 30 s were transposed in rising grayscales to visualize cell movement. (F) Percentage of migrating dHL-60 transfectants (n&#x0200a;&#x0003d;&#x0200a;63 EGFP-Syk, n&#x0200a;&#x0003d;&#x0200a;67 EGFP-Syk Y323F) from at least four independent experiments. Data represent means&#x000b1;SD, bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m.</p></caption><graphic xlink:href="pone.0001132.g001"/></fig></sec><sec id="s3b"><title>The enrichment of PI3K p110&#x003b4; at the leading edge of dHL-60 cells depends on Syk-Tyr<sup>323</sup></title><p>The class I<sub>A</sub> PI3K p110&#x003b4; is predominantly expressed in leukocytes and it is known to play an essential role in PMN chemotaxis <xref ref-type="bibr" rid="pone.0001132-Vanhaesebroeck1">&#x0005b;30&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001132-Puri1">&#x0005b;32&#x0005d;</xref>. As the precise temporal and spatial distribution of activated signal transducers is critical for the control of cell functions such as migration <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref>, we analyzed the subcellular distribution of PI3K p110&#x003b4; in polarized EGFP-Syk Y323F transfectants and in dHL-60 EGFP-Syk expressing control cells. Upon induction of cell polarization on immobilized fibrinogen with a uniform concentration of 100 nM fMLP, PI3K p110&#x003b4; staining was enriched at the lamellipodium in 68.3&#x00025; of the control cells (<xref ref-type="fig" rid="pone-0001132-g002">Figure 2A and C</xref>). In contrast, the enrichment of PI3K p110&#x003b4; at the leading edge was significantly impaired to 35.9&#x00025; in the Syk mutant although an enhanced EGFP-Syk Y323 epifluorescence similar to the control transfectants was still detectable at the lamellipodium (66.8&#x00025; and 58.0&#x00025;, respectively). The finding that intact Syk was involved in the efficient translocation of p110&#x003b4; to the leading edge was confirmed using a previously described HL-60 cell clone that downregulates Syk protein expression by stably producing a Syk specific short-interfering RNA (Syk-siRNA) <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. The Syk-siRNA dHL-60 cells formed multiple lamellipodia and showed an impaired enrichment of PI3K p110&#x003b4; at the leading edge in 37.0&#x00025; of the cells compared to 63.0&#x00025; of the wildtype cells (<xref ref-type="fig" rid="pone-0001132-g002">Figure 2B and C</xref>). These findings confirm that Syk was required for the observed asymmetric distribution of PI3K p110&#x003b4; within the cell. Recent studies have demonstrated a critical role for PI3K p110&#x003b3; in the control of PMN migration <xref ref-type="bibr" rid="pone.0001132-Hannigan1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Ferguson1">&#x0005b;34&#x0005d;</xref>. To ask whether Syk-Tyr<sup>323</sup> is required for the translocation of PI3K p110&#x003b3; during &#x003b2;<sub>2</sub> integrin-mediated adhesion and polarization in leukocytes, we analyzed the subcellular localization of PI3K p110&#x003b3; in EGFP-Syk Y323F or EGFP-Syk expressing dHL-60 cells. The majority of the polarized EGFP-Syk and EGFP-Syk Y323F expressing cells showed not only an enrichment of EGFP epifluorescence (69.3&#x00025; and 75.1&#x00025;, respectively) but also an accumulation of PI3K p110&#x003b3; staining (83.2&#x00025; and 78.2&#x00025;) at the lamellipodium forming site indicating that the translocation of the Class I<sub>B</sub> PI3K p100&#x003b3; was independent of Syk-Tyr<sup>323</sup> (<xref ref-type="fig" rid="pone-0001132-g002">Figure 2D and E</xref>).</p><fig id="pone-0001132-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g002</object-id><label>Figure 2</label><caption><title>Syk was required for the translocation of PI3K p110&#x003b4; but not of p110&#x003b3; to the leading edge.</title><p>Microscopy images of dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F (A,D) or stably expressing a Syk-siRNA (siSyk) (B). Upon stimulation by 100 nM fMLP on immobilized fibrinogen, PI3K p110&#x003b4; was enriched at the lamellipodium (arrow) of (A) EGFP-Syk transfectants and (B) dHL-60 control cells (WT). In contrast, dHL-60 cells expressing EGFP-Syk Y323F or Syk-siRNA (siSyk) showed an impaired enrichment of PI3K p110&#x003b4; staining at the leading edge (arrow heads). (C) Quantitative analysis of subcellular Syk and PI3K p110&#x003b4; distribution using microscopic images of fixed dHL-60 cells from at least three independent experiments. (n&#x0200a;&#x0003d;&#x0200a;67 EGFP-Syk, n&#x0200a;&#x0003d;&#x0200a;88 EGFP-Syk Y323F; n&#x0200a;&#x0003d;&#x0200a;210 WT, n&#x0200a;&#x0003d;&#x0200a;138 Syk-siRNA). (D) PI3K p110&#x003b3; was translocated to the leading edge in EGFP-Syk (arrow) as well as in EGFP-Syk Y323F transfectants (arrow heads). (C) Quantitative analysis (n&#x0200a;&#x0003d;&#x0200a;48 EGFP-Syk, n&#x0200a;&#x0003d;&#x0200a;49 EGFP-Syk Y323F). Data represent means&#x000b1;SD, bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m.</p></caption><graphic xlink:href="pone.0001132.g002"/></fig><p>Since it is known that the adaptor protein Cbl binds to Syk-Tyr<sup>323</sup><xref ref-type="bibr" rid="pone.0001132-Lupher1">&#x0005b;35&#x0005d;</xref> and expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement <xref ref-type="bibr" rid="pone.0001132-Caveggion1">&#x0005b;17&#x0005d;</xref>, we analyzed the EGFP-Syk transfectants and Syk-siRNA expressing cells for the subcellular distribution of Cbl (<xref ref-type="fig" rid="pone-0001132-g003">Figure 3</xref>). The majority of EGFP-Syk expressing control cells as well as EGFP-Syk Y323F transfectants showed enrichment of Syk (70.2&#x00025; and 73.1&#x00025;) and of Cbl (80.3&#x00025; and 71.8&#x00025;) at the leading edge. Moreover, downregulation of Syk by RNAi technique did not affect the translocation of Cbl to the leading edge indicating that Syk-Tyr<sup>323</sup> as well as a certain threshold of Syk protein was not required for the enrichment of Cbl at the lamellipodium forming site. Thus, Syk-Tyr<sup>323</sup> is specifically required for accumulation of PI3K p110&#x003b4; but dispensable for the enrichment of Cbl at the leading edge. In a previous study, we have shown that Syk-Tyr<sup>348</sup> was indispensable for the recruitment of the guanine nucleotide exchange factor Vav to the leading edge and the control of leukocyte migration <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. However, this process seems to be independent of Syk-Tyr<sup>323</sup>-mediated signaling, since the enrichment of Vav at the leading edge was not affected in the Syk-Tyr<sup>323</sup> mutants (supporting information <xref ref-type="supplementary-material" rid="pone.0001132.s001">Figure S1</xref> A and E). To investigate whether Syk-Tyr<sup>323</sup> has an impact on the translocation of other potential downstream signaling components of Syk, we investigated the subcellular localization of dedicator of cytokinesis 2 (Dock2), PLC&#x003b3;-1 and PLC&#x003b3;-2 in dHL-60 cells expressing wildtype Syk and the Syk mutant. Dock2, an activator of Rac and a member of the CDM family proteins (<italic>Caenorhabditis elegans</italic> CDE-5, mammalian Dock180 and <italic>Drosophila melanogaster</italic> Myoblast City), has been recently described to be required for the migration and polarization during PMN chemotaxis and its translocation to the leading edge has been reported to depend on PI3K activity <xref ref-type="bibr" rid="pone.0001132-Kunisaki1">&#x0005b;36&#x0005d;</xref>. However, the translocation of all these proteins to the leading edge did not depend on Syk-Tyr<sup>323</sup> (supporting information <xref ref-type="supplementary-material" rid="pone.0001132.s001">Figure S1</xref> B&#x02013;E). Thus, Syk-Tyr<sup>323</sup> seems to be specifically required for the enrichment of PI3K p110&#x003b4; to the leading edge of polarized leukocytes.</p><fig id="pone-0001132-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g003</object-id><label>Figure 3</label><caption><title>The enrichment of Cbl at the lamellipodium was not dependent on Syk-Tyr<sup>323</sup>.</title><p>Confocal microscopy images of dHL-60 cells (A) expressing EGFP-Syk or EGFP-Syk Y323F or (B) stably expressing a Syk-siRNA (siSyk). Upon stimulation by 100 nM fMLP on immobilized fibrinogen, Cbl was enriched at the lamellipodium of (A) EGFP-Syk transfectants and (B) dHL-60 control cells (arrow and arrow heads). A similar result was obtained in dHL-60 cells expressing EGFP-Syk Y323F or siSyk. (C) Quantitative analysis of subcellular Syk and Cbl distribution using microscopic images of fixed dHL-60 cells taken from three independent experiments (n&#x0200a;&#x0003d;&#x0200a;77 EGFP-Syk, n&#x0200a;&#x0003d;&#x0200a;78 EGFP-Syk Y323F; n&#x0200a;&#x0003d;&#x0200a;177 WT, n&#x0200a;&#x0003d;&#x0200a;105 Syk-siRNA). Data represent means&#x000b1;SD. Bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m.</p></caption><graphic xlink:href="pone.0001132.g003"/></fig></sec><sec id="s3c"><title>The spatio-temporal control of PI3K activity is mediated by Syk-Tyr<sup>323</sup></title><p>To study the functional relevance of the impaired translocation of PI3K p110&#x003b4; to the leading edge, we measured PI3K activity indirectly using the PH-AKT-GFP HL-60 cell line. This cell line constitutively expresses the pleckstrin homologous (PH) domain of the AKT kinase fused to an EGFP tag that functions as a biosensor for PI3K activity by binding to PI3K products in live cells <xref ref-type="bibr" rid="pone.0001132-Servant1">&#x0005b;27&#x0005d;</xref>. In suspended PH-AKT-GFP dHL-60 cells, Syk and PH-AKT epifluorescence were homogenously distributed after stimulation (<xref ref-type="fig" rid="pone-0001132-g004">Figure 4A</xref>). Upon induction of cell adhesion on immobilized fibrinogen with 0.2 mM Mn<sup>2&#x0002b;</sup> or 100 nM fMLP, the biosensor PH-AKT-GFP was enriched at the lamellipodium of dHL-60 cells indicating a role of &#x003b2;<sub>2</sub> integrin-mediated adhesion and signaling for the subcellular generation of PI3K products. To analyze the role of Syk for the activation of PI3K, we used the Syk specific inhibitor piceatannol (<xref ref-type="fig" rid="pone-0001132-g004">Figure 4B</xref>). Upon inhibition of Syk, the cells formed multiple lamellipodia in response to fMLP-stimulation and showed a decreased enrichment of PH-AKT-GFP epifluorescence at the lamellipodium (from 78.5&#x00025; of the control cells to 44.7&#x00025; in the piceatannol treated cells) indicating a role of Syk for the maintenance of cell polarity by the spatio-temporal control of PI3K activity (<xref ref-type="fig" rid="pone-0001132-g004">Figure 4D</xref>). This finding is consistent with the view that the local generation of PI3K products at the leading edge provides a positive feedback signal that is required for the consolidation of the leading edge <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>. To address specifically the role of Syk Tyr<sup>323</sup> in the regulation of PI3K activity we analyzed PH-AKT-GFP dHL-60 cells expressing fusion proteins of wildtype Syk or the Syk Y323F mutant with the red fluorescent reporter protein mCherry (mCherry-Syk and mCherry-Syk Y323F, respectively). Similar to the experiments described above, mCherry-Syk as well as PH-Akt-GFP were enriched at the leading edge in the majority of polarized PH-Akt-GFP dHL-60 cells on immobilized fibrinogen after the stimulation with 100 nM fMLP (81.3&#x00025; and 81.8&#x00025;, respectively; <xref ref-type="fig" rid="pone-0001132-g004">Figure 4C and 4D</xref>). In accordance with the result obtained upon pharmacological inhibition of Syk using piceatannol the expression of mCherry-Syk Y323F led to an impaired translocation of PH-AKT-GFP to the lamellipodium in 49.1&#x00025; of the dHL-60 cells. In contrast to the cells expressing EGFP-Syk Y323F alone (<xref ref-type="fig" rid="pone-0001132-g001">Figure 1</xref>), cells expressing both PH-AKT-GFP and mCherry-Syk Y323F showed an attenuated enrichment of mCherry-Syk Y323 at the leading edge which may reflect the breakdown of PI3K signaling caused by the overexpression of PH-AKT-GFP in combination with hampered PI3K&#x003b4; signaling. However, the underlying mechanism is unknown. Nevertheless, our results demonstrate that Syk-Tyr<sup>323</sup> is involved in the complex spatio-temporal regulation of PI3K activity.</p><fig id="pone-0001132-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g004</object-id><label>Figure 4</label><caption><title>Syk activity was required for the enrichment of PI3K products at the leading edge.</title><p>Microscopy images of PH-AKT-GFP dHL-60 cells in suspension (sus) or after induction of adhesion (ad) to immobilized fibrinogen in the presence of 0.2 mM Mn<sup>2&#x0002b;</sup> (A), or adhered and polarized after the induction with 100 nM fMLP (B, C). PH-AKT-GFP dHL-60 cells were treated with 30 &#x000b5;M piceatannol (&#x0002b;Pic) or vehicle for control (-Pic) (B), or expressed mCherry-Syk or mCherry-Syk Y323F (C). PH-AKT-GFP dHL-60 cells stimulated in suspension did not translocate Syk or PH-AKT-GFP (EGFP) to the membrane. In contrast, adherent cells showed an enriched Syk staining, or mCherry-Syk and PH-AKT-GFP epifluorescence at the lamellipodium forming site (arrow). Inhibition of Syk or the expression of mCherry-Syk Y323F increased the population of cells with a homogenous distribution of Syk and a diminished concentration of PH-AKT-GFP at the lamellipodium forming site (arrow head). Pictures are representative for at least three independent experiments. (D) Quantitative analysis of the subcellular localization of Syk, mCherry-Syk or mCherry-Syk Y323F (Syk LA) or PH-AKT-GFP epifluorescence (PH LA) at the lamellipodium in PH-AKT-GFP dHL-60 cells taken from at least three experiments (n&#x0200a;&#x0003d;&#x0200a;137&#x02212;Pic, n&#x0200a;&#x0003d;&#x0200a;157&#x0002b;Pic; n&#x0200a;&#x0003d;&#x0200a;113 mCherry-Syk, n&#x0200a;&#x0003d;&#x0200a;99 mCherry-Syk Y323F). Data represent means&#x000b1;SD. Bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m.</p></caption><graphic xlink:href="pone.0001132.g004"/></fig></sec><sec id="s3d"><title>The role of Syk in native PMN</title><p>To address the relevance of Syk for the translocation of PI3K p110&#x003b4; or p100&#x003b3; in native PMN, we isolated and analyzed murine PMN from the bone marrow of wildtype mice reconstituted with a Syk-deficient or a Syk heterozygous hematopoietic system for control. After the induction of cell polarization with 1 &#x000b5;M fMLP on immobilized fibrinogen, the majority of the control cells translocated PI3K p110&#x003b4; (86.3&#x00025;) and PI3K p110&#x003b3; (84.6&#x00025;) to the leading edge (<xref ref-type="fig" rid="pone-0001132-g005">Figure 5A, B and C</xref>). In contrast, Syk deficient PMN showed a diminished translocation of class I<sub>A</sub> PI3K p110&#x003b4; (41.9&#x00025;) whereas class I<sub>B</sub> PI3K p110&#x003b3; (75.6&#x00025;) was still enriched at the lamellipodium forming sites (<xref ref-type="fig" rid="pone-0001132-g005">Figure 5A, B and C</xref>). These findings are in accordance with the above described results using the dHL-60 cells and propose a selective role for Syk in the spatio-temporal control of the class I<sub>A</sub> PI3K p110&#x003b4; in native murine PMN. It is known that PI3K p110&#x003b4; is critically involved in the recruitment of PMN into inflamed tissue <xref ref-type="bibr" rid="pone.0001132-Puri1">&#x0005b;32&#x0005d;</xref>. To address the functional relevance of Syk for PMN infiltration and wound healing in a skin model of inflammation and repair, we produced full-thickness excisional wounds on the back of wildtype mice reconstituted with a Syk deficient or a Syk heterozygous hematopoietic system for control. PMN infiltration into the wound area was analyzed 24 h after wounding by immunostaining using the PMN specific GR-1 antibody (<xref ref-type="fig" rid="pone-0001132-g005">Figure 5A</xref>). In the wounds of mice with a Syk deficient hematopoietic system, the number of PMN (24.2&#x000b1;4.8 PNM per high power field) was significantly decreased compared to control mice (96.1&#x000b1;9.5 PMN per high power field; <xref ref-type="fig" rid="pone-0001132-g005">Figure 5B</xref>). Furthermore, wound closure was significantly delayed after 10 days in WT mice with a Syk deficient hematopoietic system to 37.0&#x00025; compared to control mice were the wound size was reduced to 17.8&#x00025; of the initial wound area of 100&#x00025; (<xref ref-type="fig" rid="pone-0001132-g005">Figure 5C</xref>). Thus, our findings indicate a role of hematopoietic Syk for PMN infiltration into the wounded tissue and for cutaneous wound healing.</p><fig id="pone-0001132-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g005</object-id><label>Figure 5</label><caption><title>Syk was required for the enrichment of PI3K p110&#x003b4; at the leading edge of murine PMN and delayed wound closure.</title><p>(A,B) Confocal microscopy images of Syk-deficient (Syk<sup>&#x02212;/&#x02212;</sup>) and control (Syk<sup>&#x02212;/&#x0002b;</sup>) PMN of bone marrow chimeric mice. Upon stimulation by 1 &#x000b5;M fMLP on immobilized fibrinogen, PI3K p110&#x003b4; and PI3K p110&#x003b3; were enriched at the lamellipodium (arrow) of polarized cells. In contrast, Syk<sup>&#x02212;/&#x02212;</sup> PMN showed an impaired enrichment of PI3K p110&#x003b4; staining at the leading edge (arrow heads, A) whereas PI3K p110&#x003b3; was still translocated to the lamellipodium forming sites (&#x00392;). Bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m. (C) Quantitative analysis of subcellular localization of PI3K p110&#x003b4; and PI3K p110&#x003b3; distribution using microscopic images of fixed murine PMN from at four independent experiments. Data represent means&#x000b1;SD. (D) 24 h old wound sections of wildtype mice reconstituted with a Syk<sup>&#x02212;/&#x02212;</sup> or a Syk<sup>&#x0002b;/&#x02212;</sup> hematopoietic system for control stained with the PMN specific Gr-1 antibody (upper panel) or GR-1 antibody and DAPI (lower panel). Control sections showed substantial infiltration of Syk<sup>&#x0002b;/&#x02212;</sup> PMN (arrows) into the wounded tissue (wm: wound margin at dotted line, es: eschar). In contrast, Syk<sup>&#x02212;/&#x02212;</sup> PMN migration into the wounded tissue was impaired. Scale bars, 100 &#x000b5;m. (E) Quantitative analysis of PMN numbers per HPF in the wound tissue using microscopic images. (F) Wound sizes at given time points after wounding is displayed as percentage of initial (day 0) wound area for Syk<sup>&#x0002b;/&#x02212;</sup> (&#x025cb;) or Syk<sup>&#x02212;/&#x02212;</sup> (&#x025b4;) bone marrow chimeric mice (100&#x00025;). Data represent means&#x000b1;SD; n&#x0200a;&#x0003d;&#x0200a;5 mice with four wounds per animal; p<sub>day3</sub>&#x0200a;&#x0003d;&#x0200a;0.24, &#x0002a;p<sub>day5&#x02013;10</sub>&#x0003c;0.001.</p></caption><graphic xlink:href="pone.0001132.g005"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>PMN are the first inflammatory cells invading the wound site after injury. Besides their defense functions against intruding microorganisms, PMN are an important source of signals that are essential for the control of their own accumulation, activation and apoptosis as well as for the attraction of macrophages and the orchestration of tissue repair including elimination of cell debris <xref ref-type="bibr" rid="pone.0001132-Nathan1">&#x0005b;1&#x0005d;</xref>. An essential step during PMN recruitment to sites of lesion are the processes of intravascular crawling and of cell migration within the tissue. PI3K signaling is known to be required for the establishment and the maintenance of cell polarity by regulating the subcellular localization and activation of downstream effectors that are essential for proper chemotaxis <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>. Here, we show that Syk-Tyr<sup>323</sup>, the binding site for the regulatory subunit p85 of the PI3K class I<sub>A</sub>, was required for the enrichment of PI3K p110&#x003b4; at the lamellipodium of polarized dHL-60 cells (<xref ref-type="fig" rid="pone-0001132-g002">Figure 2</xref> and <xref ref-type="fig" rid="pone-0001132-g006">6</xref>). This signaling step was critical for the consolidation and the stability of the leading edge and for efficient migration of dHL-60 cells on immobilized fibrinogen. This effect may be specific for class I<sub>A</sub> PI3K since the translocation of PI3K&#x003b3; was not dependent on Syk-Tyr<sup>323</sup>. A requirement of PI3K p110&#x003b4; activity in the control of chemotaxis has been demonstrated for human PMN in an under agarose assay <xref ref-type="bibr" rid="pone.0001132-Sadhu1">&#x0005b;31&#x0005d;</xref> and for murine PMN in a transwell assay <xref ref-type="bibr" rid="pone.0001132-Puri1">&#x0005b;32&#x0005d;</xref>. However, random movement seemed not to be dependent on PI3K p110&#x003b4; activity at least in the human system <xref ref-type="bibr" rid="pone.0001132-Sadhu1">&#x0005b;31&#x0005d;</xref>. Similarly, the inhibition of PI3K p110&#x003b3; has been found to induce the formation of multiple transient lamellipodia and to inhibit migration of dHL-60 cells on immobilized fibronectin towards fMLP <xref ref-type="bibr" rid="pone.0001132-VanKeymeulen1">&#x0005b;37&#x0005d;</xref>. However, in this setting the pharmacological inhibition of PI3K p110&#x003b4; by using the compound IC87114 had no effect on cell polarization and chemotaxis <xref ref-type="bibr" rid="pone.0001132-VanKeymeulen1">&#x0005b;37&#x0005d;</xref>. A reason for these controversial findings could be that the regulation of PI3K p110&#x003b4; and p110&#x003b3; activity may be substrate specific. This would be in accordance with a study of Ferguson et al. showing that the motility of PI3K p110&#x003b3;-deficient PMN compared to control cells was not significantly reduced on glass, but it was significantly impaired on surfaces to which the cells bind less tightly, namely fibrinogen or polycarbonate <xref ref-type="bibr" rid="pone.0001132-Ferguson1">&#x0005b;34&#x0005d;</xref>. However, the PMN migration assay was conducted on immobilized fibrinogen in the present study. In this model, PMN migration strongly depends on &#x003b2;<sub>2</sub> integrins <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref> and thereby reflects an inflammatory situation in vivo where PMN migrate on fibrin within the inflamed interstitial space.</p><fig id="pone-0001132-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001132.g006</object-id><label>Figure 6</label><caption><title>Model for localized accumulation of PI3K products at the leading edge of migrating leukocytes.</title><p>Upon &#x003b2;<sub>2</sub> integrin-mediated adhesion of PMN, the ITAM-bearing adaptor proteins DAP12 and/or the FcR &#x003b3;-chain are phosphorylated by Src-family kinases. Syk binds to the phosphorylated ITAM, becomes activated and enriched at the leading edge. DAP12 and the FcR &#x003b3;-chain are associated with different receptors, but it is unknown to date how these receptors interact with the &#x003b2;<sub>2</sub> integrin Mac-1. Here, we have shown that Syk-Tyr<sup>323</sup> and Syk activity were required for the recruitment of PI3K p110&#x003b4; and the accumulation of PI3K products at the cell front. In contrast, the translocation of PI3K p110&#x003b3; to the leading edge was independent of Syk activity and Syk-Tyr<sup>323</sup>. Translocation and activation of PI3K p110&#x003b3; is mediated by GPCR-mediated signaling. Upon GPCR activation the &#x003b1;-subunit of the heterotrimeric G<sub>i</sub> protein dissociates from the receptor and the &#x003b2;&#x003b3;-subunit <xref ref-type="bibr" rid="pone.0001132-Wettschureck1">&#x0005b;22&#x0005d;</xref>. The &#x003b2;&#x003b3;-complex of the G protein is known to activate PI3K&#x003b3; <xref ref-type="bibr" rid="pone.0001132-Deane1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Hawkins1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Wettschureck1">&#x0005b;22&#x0005d;</xref>. Taken together, Syk activity and Syk-Tyr<sup>323</sup> mediated signaling via PI3K p110&#x003b4; was required for the persistent accumulation of PI3K products at the cell front which is a prerequisite for the stabilization of the leading edge and efficient migration.</p></caption><graphic xlink:href="pone.0001132.g006"/></fig><p>Syk-Tyr<sup>323</sup> has been described to be required for the binding of the phosphotyrosine-binding (PTB) domain of Cbl <xref ref-type="bibr" rid="pone.0001132-Lupher1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Yankee1">&#x0005b;38&#x0005d;</xref>. However, our findings suggest that this interaction is not necessary for the translocation of Cbl to the leading edge. We have shown previously that the Syk substrate Cbl becomes tyrosine phosphorylated upon &#x003b2;<sub>2</sub> integrin-mediated adhesion of human PMN suggesting a functional link between Syk and Cbl <xref ref-type="bibr" rid="pone.0001132-Willeke1">&#x0005b;39&#x0005d;</xref>. Accordingly, a negative regulatory function of Cbl in Syk-Tyr<sup>323</sup>-mediated signaling has been described to be required for the control of different biochemical pathways in B cells, e.g. for the activation of the transcription factor NF-AT or for B cell antigen receptor induced Ca<sup>2&#x0002b;</sup> mobilization <xref ref-type="bibr" rid="pone.0001132-Lupher1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Yankee1">&#x0005b;38&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Hong1">&#x0005b;40&#x0005d;</xref>, and for the control of histamine release in mast cells <xref ref-type="bibr" rid="pone.0001132-Sada2">&#x0005b;41&#x0005d;</xref>. Furthermore, Cbl was involved in the recruitment of p85 to CD28 in T cells <xref ref-type="bibr" rid="pone.0001132-Fang1">&#x0005b;42&#x0005d;</xref>. Thus, Syk-Tyr<sup>323</sup> seems not to be involved in the tranlsocation of Cbl which may not be true for the regulation of the function of Cbl.</p><p>Recently, we have reported that the redistribution of Vav depended on Syk activity and the binding site of Vav, Syk-Tyr<sup>348</sup><xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. In this study, we have shown that Syk-Tyr<sup>323</sup> was not required for the translocation of Vav to the leading edge. However, effective binding of Vav, PLC&#x003b3;-1 and PLC&#x003b3;-2, to Syk is mediated by the phosphorylation of the Syk tyrosines Syk-Tyr<sup>348</sup> and Syk-Tyr<sup>352</sup><xref ref-type="bibr" rid="pone.0001132-Groesch1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Deckert1">&#x0005b;43&#x0005d;</xref>. Therefore, the translocation of Vav (and perhaps also PLC&#x003b3;-1 and PLC&#x003b3;-2) to the leading edge may be still supported by the redistribution of Syk via &#x003b2;<sub>2</sub> integrins; a process that seems to be independent of Syk-Tyr<sup>323</sup>. Similar to Vav, PLC&#x003b3;, can be recruited to the cell membrane via its pleckstrin homologous (PH) domain that binds the PI3K products, PI(3,4)P<sub>2</sub> and/or PIP<sub>3</sub><xref ref-type="bibr" rid="pone.0001132-Kunisaki1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Turner2">&#x0005b;44&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Rebecchi1">&#x0005b;45&#x0005d;</xref>. However, our results showed clearly that at least the activity of PI3K p110&#x003b4; was not required for the enrichment of Vav and the two PLC&#x003b3; isoforms at the leading edge. Since it has been described that not just the translocation but also the enzyme activity of Vav is regulated by the lipid products of the PI3K it is possible that Syk-Tyr<sup>323</sup> could play a role in the modulation of the Vav activity at the leading edge <xref ref-type="bibr" rid="pone.0001132-Han1">&#x0005b;46&#x0005d;</xref>. Therefore, Syk-Tyr<sup>323</sup> as well as Syk-Tyr<sup>348</sup> may be required for the spatio-temporal coordination of Vav-mediated and PI3K p110&#x003b4;-mediated signaling pathways, a prerequisite for efficient &#x003b2;<sub>2</sub> integrin-mediated migration of PMN.</p><p>In the present study, we demonstrate that Syk activity was required for the formation of PI3K products at the leading edge of polarized dHL-60 on immobilized fibrinogen. The enrichment of PI3K products, especially PIP3, is regulated by different feed-forward mechanisms and is essential for the stabilization of cell polarity <xref ref-type="bibr" rid="pone.0001132-VanHaastert1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-VanKeymeulen1">&#x0005b;37&#x0005d;</xref>. The spatio-temporal control of PI3K p110&#x003b4; activity by Syk may be involved in the amplification of migratory signals and may be critical for the localization of this process at the leading edge (<xref ref-type="fig" rid="pone-0001132-g006">Figure 6</xref>). In accordance with our findings, Popa-Nita et al. have shown recently that the stimulation of human PMN with monosodium urate crystals led to the stimulation of class I<sub>A</sub> PI3K by a mechanism that was dependent on Syk activity and induced the formation of a complex containing the PI3K regulatory subunit p85 and Syk <xref ref-type="bibr" rid="pone.0001132-PopaNita1">&#x0005b;25&#x0005d;</xref>. Although, the molecular mechanism underlying the activation of PI3K and Syk was not addressed in this study it strongly suggests a potential role of Syk-mediated signaling via class I<sub>A</sub> PI3K in inflammatory diseases, e.g. gout or gouty arthritis <xref ref-type="bibr" rid="pone.0001132-PopaNita1">&#x0005b;25&#x0005d;</xref>. Furthermore, two recent studies have shown that the fMLP-dependent generation of PI3K products was bi-phasic in neutrophil-like differentiated PLB-85 cells <xref ref-type="bibr" rid="pone.0001132-Boulven1">&#x0005b;47&#x0005d;</xref> and in murine PMN <xref ref-type="bibr" rid="pone.0001132-Condliffe1">&#x0005b;48&#x0005d;</xref>. In the second phase PI3K products were generated by PI3K p110&#x003b4;. This second phase was dependent on the first phase generated by PI3K p110&#x003b3; indicating a functional cross talk between Class I<sub>A</sub> and I<sub>B</sub> PI3K signaling <xref ref-type="bibr" rid="pone.0001132-Condliffe1">&#x0005b;48&#x0005d;</xref>.</p><p>In this study, we present evidence that hematopoietic Syk was required for PMN recruitment to wounded tissue and for subsequent wound healing. In accordance with these findings, we reported previously that Syk was required for PMN adhesion and migration in the model of the inflamed cremaster muscle in vivo <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. Similar in vivo effects characterized by delayed wound closure due to impaired PMN infiltration and reduced myofibroblast differentiation have been described for CD18<sup>&#x02212;/&#x02212;</sup> mice <xref ref-type="bibr" rid="pone.0001132-Peters1">&#x0005b;28&#x0005d;</xref>. Accordingly, impaired neovascularization of the granulation tissue has been reported in CD18<sup>&#x02212;/&#x02212;</sup> mice which may imply that the impairment of inflammation-mediated angiogenesis may contribute to poor wound healing in the absence of efficient PMN infiltration <xref ref-type="bibr" rid="pone.0001132-Schruefer1">&#x0005b;49&#x0005d;</xref>. In a human model of wounded skin, PMN have been demonstrated to differentially express genes that are known to be important for the modulation of the inflammatory response of macrophages, T cells and themselves <xref ref-type="bibr" rid="pone.0001132-TheilgaardMonch1">&#x0005b;50&#x0005d;</xref>. Interestingly, PMN seem to change the responsiveness to chemotactic and immunoregulatory mediators once they have migrated to skin lesions and have been activated <xref ref-type="bibr" rid="pone.0001132-TheilgaardMonch1">&#x0005b;50&#x0005d;</xref>. Furthermore, the up-regulation of different genes in PMN could play a critical role in the mediation and regulation of processes which are critical for wound healing, e.g. the breakdown of fibrin clots and degradation of extracellular matrix, the promotion of angiogenesis and the migration and proliferation of keratinocytes and fibroblasts <xref ref-type="bibr" rid="pone.0001132-TheilgaardMonch1">&#x0005b;50&#x0005d;</xref>. Moreover, CD18 has been shown to be critically involved in homing of endothelial progenitor cells (EPC) and in neovascularization after ischemia and reperfusion injury <xref ref-type="bibr" rid="pone.0001132-Chavakis1">&#x0005b;51&#x0005d;</xref>. Two recent studies have demonstrated a role for Syk and its substrate SLP-76 for vascular and lymphatic development and repair, a process which critically depended on EPC function in a cell-autonomous way <xref ref-type="bibr" rid="pone.0001132-Sebzda1">&#x0005b;52&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Abtahian2">&#x0005b;53&#x0005d;</xref> and on integrin-mediated signaling <xref ref-type="bibr" rid="pone.0001132-Abtahian1">&#x0005b;8&#x0005d;</xref>. Thus, CD18-mediated Syk signaling seems to be of functional importance for the early recruitment of blood-derived cells including e.g. EPC as well as PMN into the inflamed tissue.</p><p>A growing body of evidence indicate that PI3K and/or Syk may represent promising targets for the treatment of diverse inflammatory disorders that are triggered by uncontrolled innate and adaptive immune responses <xref ref-type="bibr" rid="pone.0001132-Schymeinsky2">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001132-Rommel1">&#x0005b;54&#x0005d;</xref>. For example, the inhibition of PI3K p110&#x003b4; led to reduced PMN-mediated lung inflammation in a murine asthma model <xref ref-type="bibr" rid="pone.0001132-Lee1">&#x0005b;55&#x0005d;</xref>. In a previous study, we demonstrated that Syk activity was required for efficient PMN recruitment in two different murine models of acute inflammation, i.e. the reverse Arthus reaction and the inflamed cremaster muscle <xref ref-type="bibr" rid="pone.0001132-Schymeinsky1">&#x0005b;10&#x0005d;</xref>. In accordance with our in vivo findings, a study by Puri et al. revealed a role for PI3K p110&#x003b4; in mediating PMN-endothelial interactions and PMN extravasation into the inflamed tissue <xref ref-type="bibr" rid="pone.0001132-Puri1">&#x0005b;32&#x0005d;</xref>. Moreover, a recent study by Liu et al. demonstrated by means of intravital microscopy that PI3K p110&#x003b3; and p110&#x003b4; have temporally distinct roles for leukocyte recruitment into the inflamed cremaster muscle of mice <xref ref-type="bibr" rid="pone.0001132-Liu1">&#x0005b;56&#x0005d;</xref>. Leukocyte emigration was impaired in PI3K p110&#x003b3;-deficient mice in an early response (within the first 90 min) to the CXC chemokines MIP-2 (CXCL2) or KC (CXCL1). In contrast, the pharmacological inhibition of PI3K p110&#x003b4; had no effect on the early leukocyte recruitment but it diminished late (after 4&#x02013;5 h) chemokine-induced PMN recruitment into inflamed tissue in vivo <xref ref-type="bibr" rid="pone.0001132-Liu1">&#x0005b;56&#x0005d;</xref>. Taken together, we propose a novel role of Syk for the spatio-temporal control of PI3K p110&#x003b4; activity during &#x003b2;<sub>2</sub> integrin-mediated migration of PMN which seems to be important for efficient PMN recruitment into the wounded tissue and cutaneous wound closure (<xref ref-type="fig" rid="pone-0001132-g006">Figure 6</xref>).</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0001132.s001"><label>Figure S1</label><caption><p>Syk-Tyr<sup>323</sup> was not required for the tranlsocation of Vav, PLC&#x003b3;-1, PLC&#x003b3;-2 and Dock2. Confocal microscopy images of dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F. Upon stimulation by 100 nM fMLP on immobilized fibrinogen, Vav (A), PLC&#x003b3;-1 (B), PLC&#x003b3;-2 (C), or Dock2 (E) were enriched at the lamellipodium of EGFP-Syk as well as of EGFP-Syk Y323F transfectants (arrows and arrow heads). However, PLC&#x003b3;-2 and EGFP-Syk Y323F colocalization at the leading edge was absent or weak in some lamellipodia (open arrowhead). (F) Quantitative analysis using microscopic images of fixed dHL-60 cells were taken from three (A,B,C) or two (D) independent experiments. Data represent means&#x000b1;SD. Bar&#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m.</p><p>(3.74 MB TIF)</p></caption><media xlink:href="pone.0001132.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0001132.s002"><label>Movie S1</label><caption><p>Time-lapse microscopy of dHL-60 cells transiently expressing EGFP-Syk. Migration was analyzed in IBIDI-&#x000b5; slides on immobilized fibrinogen in response to a gradient of 10 nM fMLP. Images were recorded at intervals of 30 s. The movie is representative for at least three independent experiments.</p><p>(2.40 MB MOV)</p></caption><media xlink:href="pone.0001132.s002.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0001132.s003"><label>Movie S2</label><caption><p>Time-lapse microscopy of dHL-60 cells transiently expressing EGFP-Syk Y323F. Migration was analyzed in IBIDI-&#x000b5; slides on immobilized fibrinogen in response to a gradient of 10 nM fMLP. Images were recorded at intervals of 30 s. The movie is representative for at least three independent experiments.</p><p>(2.74 MB MOV)</p></caption><media xlink:href="pone.0001132.s003.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Mrs. Silvia Weidner for her expert technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0001132-Nathan1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>Neutrophils and immunity: challenges and opportunities.</article-title><source>Nat Rev Immunol</source><volume>6</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">16498448</pub-id></citation></ref><ref id="pone.0001132-Eming1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>SA</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name><name><surname>Davidson</surname><given-names>JM</given-names></name></person-group><year>2007</year><article-title>Inflammation in wound repair: molecular and cellular mechanisms.</article-title><source>Journal of Investigative Dermatology</source><volume>127</volume><fpage>514</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">17299434</pub-id></citation></ref><ref id="pone.0001132-VanHaastert1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Haastert</surname><given-names>PJ</given-names></name><name><surname>Devreotes</surname><given-names>PN</given-names></name></person-group><year>2004</year><article-title>Chemotaxis: signalling the way forward.</article-title><source>Nat Rev Mol Cell Biol</source><volume>5</volume><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">15366706</pub-id></citation></ref><ref id="pone.0001132-Anderson1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>DC</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><year>1987</year><article-title>Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins.</article-title><source>Annu Rev Med</source><volume>38</volume><fpage>175</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">3555290</pub-id></citation></ref><ref id="pone.0001132-Hynes1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group><year>2002</year><article-title>Integrins: bidirectional, allosteric signaling machines.</article-title><source>Cell</source><volume>110</volume><fpage>673</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">12297042</pub-id></citation></ref><ref id="pone.0001132-Phillipson1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillipson</surname><given-names>M</given-names></name><name><surname>Heit</surname><given-names>B</given-names></name><name><surname>Colarusso</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Ballantyne</surname><given-names>CM</given-names></name><etal/></person-group><year>2006</year><article-title>Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade.</article-title><source>J Exp Med</source><volume>203</volume><fpage>2569</fpage><lpage>2575</lpage><pub-id pub-id-type="pmid">17116736</pub-id></citation></ref><ref id="pone.0001132-Mcsai1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f3;csai</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Tybulewicz</surname><given-names>VL</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><year>2002</year><article-title>Syk is required for integrin signaling in neutrophils.</article-title><source>Immunity</source><volume>16</volume><fpage>547</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">11970878</pub-id></citation></ref><ref id="pone.0001132-Abtahian1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Bezman</surname><given-names>N</given-names></name><name><surname>Clemens</surname><given-names>R</given-names></name><name><surname>Sebzda</surname><given-names>E</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><etal/></person-group><year>2006</year><article-title>Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells.</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>6936</fpage><lpage>6949</lpage><pub-id pub-id-type="pmid">16943434</pub-id></citation></ref><ref id="pone.0001132-Mcsai2"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f3;csai</surname><given-names>A</given-names></name><name><surname>Abram</surname><given-names>CL</given-names></name><name><surname>Jakus</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><etal/></person-group><year>2006</year><article-title>Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs.</article-title><source>Nat Immunol</source><volume>7</volume><fpage>1326</fpage><lpage>1333</lpage><pub-id pub-id-type="pmid">17086186</pub-id></citation></ref><ref id="pone.0001132-Schymeinsky1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schymeinsky</surname><given-names>J</given-names></name><name><surname>Sindrilaru</surname><given-names>A</given-names></name><name><surname>Frommhold</surname><given-names>D</given-names></name><name><surname>Sperandio</surname><given-names>M</given-names></name><name><surname>Gerstl</surname><given-names>R</given-names></name><etal/></person-group><year>2006</year><article-title>The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for &#x003b2;<sub>2</sub> integrin (CD11/CD18)-mediated neutrophil migration.</article-title><source>Blood</source><volume>108</volume><fpage>3919</fpage><lpage>3927</lpage><pub-id pub-id-type="pmid">16882714</pub-id></citation></ref><ref id="pone.0001132-Schymeinsky2"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schymeinsky</surname><given-names>J</given-names></name><name><surname>Mocsai</surname><given-names>A</given-names></name><name><surname>Walzog</surname><given-names>B</given-names></name></person-group><year>2007</year><article-title>Neutrophil activation via &#x003b2;<sub>2</sub> integrins (CD11/CD18): molecular mechanisms and clinical implications.</article-title><source>Thromb Haemost</source><volume>98</volume><fpage>262</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">17721605</pub-id></citation></ref><ref id="pone.0001132-Berton1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berton</surname><given-names>G</given-names></name><name><surname>Mocsai</surname><given-names>A</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group><year>2005</year><article-title>Src and Syk kinases: key regulators of phagocytic cell activation.</article-title><source>Trends Immunol</source><volume>26</volume><fpage>208</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">15797511</pub-id></citation></ref><ref id="pone.0001132-Groesch1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groesch</surname><given-names>TD</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Mattila</surname><given-names>S</given-names></name><name><surname>Geahlen</surname><given-names>RL</given-names></name><name><surname>Post</surname><given-names>CB</given-names></name></person-group><year>2006</year><article-title>Structural basis for the requirement of two phosphotyrosine residues in signaling mediated by Syk tyrosine kinase.</article-title><source>J Mol Biol</source><volume>356</volume><fpage>1222</fpage><lpage>1236</lpage><pub-id pub-id-type="pmid">16410013</pub-id></citation></ref><ref id="pone.0001132-Jones1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>NP</given-names></name><name><surname>Peak</surname><given-names>J</given-names></name><name><surname>Brader</surname><given-names>S</given-names></name><name><surname>Eccles</surname><given-names>SA</given-names></name><name><surname>Katan</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>PLC&#x003b3; is essential for early events in integrin signalling required for cell motility.</article-title><source>J Cell Sci</source><volume>118</volume><fpage>2695</fpage><lpage>2706</lpage><pub-id pub-id-type="pmid">15944397</pub-id></citation></ref><ref id="pone.0001132-Mouneimne1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mouneimne</surname><given-names>G</given-names></name><name><surname>Soon</surname><given-names>L</given-names></name><name><surname>DesMarais</surname><given-names>V</given-names></name><name><surname>Sidani</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><etal/></person-group><year>2004</year><article-title>Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation.</article-title><source>J Cell Biol</source><volume>166</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">15337778</pub-id></citation></ref><ref id="pone.0001132-Sada1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sada</surname><given-names>K</given-names></name><name><surname>Takano</surname><given-names>T</given-names></name><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><year>2001</year><article-title>Structure and function of Syk protein-tyrosine kinase.</article-title><source>J Biochem (Tokyo)</source><volume>130</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">11481033</pub-id></citation></ref><ref id="pone.0001132-Caveggion1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caveggion</surname><given-names>E</given-names></name><name><surname>Continolo</surname><given-names>S</given-names></name><name><surname>Pixley</surname><given-names>FJ</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Bowtell</surname><given-names>DD</given-names></name><etal/></person-group><year>2003</year><article-title>Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement.</article-title><source>J Cell Physiol</source><volume>195</volume><fpage>276</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">12652654</pub-id></citation></ref><ref id="pone.0001132-Moon1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>KD</given-names></name><name><surname>Post</surname><given-names>CB</given-names></name><name><surname>Durden</surname><given-names>DL</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>De</surname><given-names>P</given-names></name><etal/></person-group><year>2005</year><article-title>Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>1543</fpage><lpage>1551</lpage><pub-id pub-id-type="pmid">15536084</pub-id></citation></ref><ref id="pone.0001132-Deane1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deane</surname><given-names>JA</given-names></name><name><surname>Fruman</surname><given-names>DA</given-names></name></person-group><year>2004</year><article-title>Phosphoinositide 3-kinase: diverse roles in immune cell activation.</article-title><source>Annu Rev Immunol</source><volume>22</volume><fpage>563</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">15032589</pub-id></citation></ref><ref id="pone.0001132-Hawkins1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>PT</given-names></name><name><surname>Anderson</surname><given-names>KE</given-names></name><name><surname>Davidson</surname><given-names>K</given-names></name><name><surname>Stephens</surname><given-names>LR</given-names></name></person-group><year>2006</year><article-title>Signalling through Class I PI3Ks in mammalian cells.</article-title><source>Biochem Soc Trans</source><volume>34</volume><fpage>647</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">17052169</pub-id></citation></ref><ref id="pone.0001132-Axelsson1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>L</given-names></name><name><surname>Hellberg</surname><given-names>C</given-names></name><name><surname>Melander</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><etal/></person-group><year>2000</year><article-title>Clustering of &#x003b2;<sub>2</sub>-integrins on human neutrophils activates dual signaling pathways to PtdIns 3-kinase.</article-title><source>Exp Cell Res</source><volume>256</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">10739672</pub-id></citation></ref><ref id="pone.0001132-Wettschureck1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wettschureck</surname><given-names>N</given-names></name><name><surname>Offermanns</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Mammalian G proteins and their cell type specific functions.</article-title><source>Physiol Rev</source><volume>85</volume><fpage>1159</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">16183910</pub-id></citation></ref><ref id="pone.0001132-vonWillebrand1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Willebrand</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Tailor</surname><given-names>P</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name></person-group><year>1998</year><article-title>Phosphorylation of the Grb2- and phosphatidylinositol 3-kinase p85-binding p36/38 by Syk in Lck-negative T cells.</article-title><source>Cell Signal</source><volume>10</volume><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">9720763</pub-id></citation></ref><ref id="pone.0001132-Beitz1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beitz</surname><given-names>LO</given-names></name><name><surname>Fruman</surname><given-names>DA</given-names></name><name><surname>Kurosaki</surname><given-names>T</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Scharenberg</surname><given-names>AM</given-names></name></person-group><year>1999</year><article-title>SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>32662</fpage><lpage>32666</lpage><pub-id pub-id-type="pmid">10551821</pub-id></citation></ref><ref id="pone.0001132-PopaNita1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Popa-Nita</surname><given-names>O</given-names></name><name><surname>Rollet-Labelle</surname><given-names>E</given-names></name><name><surname>Thibault</surname><given-names>N</given-names></name><name><surname>Gilbert</surname><given-names>C</given-names></name><name><surname>Bourgoin</surname><given-names>SG</given-names></name><etal/></person-group><year>2007</year><article-title>Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase.</article-title><source>J Leukoc Biol</source><volume>82</volume><fpage>763</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">17535983</pub-id></citation></ref><ref id="pone.0001132-Shaner1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaner</surname><given-names>NC</given-names></name><name><surname>Campbell</surname><given-names>RE</given-names></name><name><surname>Steinbach</surname><given-names>PA</given-names></name><name><surname>Giepmans</surname><given-names>BN</given-names></name><name><surname>Palmer</surname><given-names>AE</given-names></name><etal/></person-group><year>2004</year><article-title>Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.</article-title><source>Nat Biotechnol</source><volume>22</volume><fpage>1567</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">15558047</pub-id></citation></ref><ref id="pone.0001132-Servant1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Servant</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>OD</given-names></name><name><surname>Herzmark</surname><given-names>P</given-names></name><name><surname>Balla</surname><given-names>T</given-names></name><name><surname>Sedat</surname><given-names>JW</given-names></name><etal/></person-group><year>2000</year><article-title>Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.</article-title><source>Science</source><volume>287</volume><fpage>1037</fpage><lpage>1040</lpage><pub-id pub-id-type="pmid">10669415</pub-id></citation></ref><ref id="pone.0001132-Peters1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>T</given-names></name><name><surname>Sindrilaru</surname><given-names>A</given-names></name><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>Hinrichs</surname><given-names>R</given-names></name><name><surname>Menke</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Wound-healing defect of CD18(&#x02212;/&#x02212;) mice due to a decrease in TGF-&#x003b2;1 and myofibroblast differentiation.</article-title><source>Embo J</source><volume>24</volume><fpage>3400</fpage><lpage>3410</lpage><pub-id pub-id-type="pmid">16148944</pub-id></citation></ref><ref id="pone.0001132-Turner1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Mee</surname><given-names>PJ</given-names></name><name><surname>Costello</surname><given-names>PS</given-names></name><name><surname>Williams</surname><given-names>O</given-names></name><name><surname>Price</surname><given-names>AA</given-names></name><etal/></person-group><year>1995</year><article-title>Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.</article-title><source>Nature</source><volume>378</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">7477352</pub-id></citation></ref><ref id="pone.0001132-Vanhaesebroeck1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanhaesebroeck</surname><given-names>B</given-names></name><name><surname>Welham</surname><given-names>MJ</given-names></name><name><surname>Kotani</surname><given-names>K</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Warne</surname><given-names>PH</given-names></name><etal/></person-group><year>1997</year><article-title>P110&#x003b4;, a novel phosphoinositide 3-kinase in leukocytes.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>4330</fpage><lpage>4335</lpage><pub-id pub-id-type="pmid">9113989</pub-id></citation></ref><ref id="pone.0001132-Sadhu1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sadhu</surname><given-names>C</given-names></name><name><surname>Masinovsky</surname><given-names>B</given-names></name><name><surname>Dick</surname><given-names>K</given-names></name><name><surname>Sowell</surname><given-names>CG</given-names></name><name><surname>Staunton</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>Essential role of phosphoinositide 3-kinase &#x003b4; in neutrophil directional movement.</article-title><source>J Immunol</source><volume>170</volume><fpage>2647</fpage><lpage>2654</lpage><pub-id pub-id-type="pmid">12594293</pub-id></citation></ref><ref id="pone.0001132-Puri1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>KD</given-names></name><name><surname>Doggett</surname><given-names>TA</given-names></name><name><surname>Douangpanya</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Tino</surname><given-names>WT</given-names></name><etal/></person-group><year>2004</year><article-title>Mechanisms and implications of phosphoinositide 3-kinase &#x003b4; in promoting neutrophil trafficking into inflamed tissue.</article-title><source>Blood</source><volume>103</volume><fpage>3448</fpage><lpage>3456</lpage><pub-id pub-id-type="pmid">14751923</pub-id></citation></ref><ref id="pone.0001132-Hannigan1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannigan</surname><given-names>M</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Ai</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><etal/></person-group><year>2002</year><article-title>Neutrophils lacking phosphoinositide 3-kinase &#x003b3; show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>3603</fpage><lpage>3608</lpage><pub-id pub-id-type="pmid">11904423</pub-id></citation></ref><ref id="pone.0001132-Ferguson1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>GJ</given-names></name><name><surname>Milne</surname><given-names>L</given-names></name><name><surname>Kulkarni</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>PI(3)K&#x003b3; has an important context-dependent role in neutrophil chemokinesis.</article-title><source>Nat Cell Biol</source><volume>9</volume><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">17173040</pub-id></citation></ref><ref id="pone.0001132-Lupher1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lupher</surname><given-names>ML</given-names><suffix>Jr</suffix></name><name><surname>Rao</surname><given-names>N</given-names></name><name><surname>Lill</surname><given-names>NL</given-names></name><name><surname>Andoniou</surname><given-names>CE</given-names></name><name><surname>Miyake</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>35273</fpage><lpage>35281</lpage><pub-id pub-id-type="pmid">9857068</pub-id></citation></ref><ref id="pone.0001132-Kunisaki1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunisaki</surname><given-names>Y</given-names></name><name><surname>Nishikimi</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Takii</surname><given-names>R</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis.</article-title><source>J Cell Biol</source><volume>174</volume><fpage>647</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">16943182</pub-id></citation></ref><ref id="pone.0001132-VanKeymeulen1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Keymeulen</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Knight</surname><given-names>ZA</given-names></name><name><surname>Govaerts</surname><given-names>C</given-names></name><name><surname>Hahn</surname><given-names>KM</given-names></name><etal/></person-group><year>2006</year><article-title>To stabilize neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the back as well as signals at the front.</article-title><source>J Cell Biol</source><volume>174</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">16864657</pub-id></citation></ref><ref id="pone.0001132-Yankee1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yankee</surname><given-names>TM</given-names></name><name><surname>Keshvara</surname><given-names>LM</given-names></name><name><surname>Sawasdikosol</surname><given-names>S</given-names></name><name><surname>Harrison</surname><given-names>ML</given-names></name><name><surname>Geahlen</surname><given-names>RL</given-names></name></person-group><year>1999</year><article-title>Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.</article-title><source>J Immunol</source><volume>163</volume><fpage>5827</fpage><lpage>5835</lpage><pub-id pub-id-type="pmid">10570266</pub-id></citation></ref><ref id="pone.0001132-Willeke1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willeke</surname><given-names>T</given-names></name><name><surname>Behrens</surname><given-names>S</given-names></name><name><surname>Scharffetter-Kochanek</surname><given-names>K</given-names></name><name><surname>Gaehtgens</surname><given-names>P</given-names></name><name><surname>Walzog</surname><given-names>B</given-names></name></person-group><year>2000</year><article-title>Beta2 integrin (CD11/CD18)-mediated signaling involves tyrosine phosphorylation of c-Cbl in human neutrophils.</article-title><source>J Leukoc Biol</source><volume>68</volume><fpage>284</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">10947074</pub-id></citation></ref><ref id="pone.0001132-Hong1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>JJ</given-names></name><name><surname>Yankee</surname><given-names>TM</given-names></name><name><surname>Harrison</surname><given-names>ML</given-names></name><name><surname>Geahlen</surname><given-names>RL</given-names></name></person-group><year>2002</year><article-title>Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>31703</fpage><lpage>31714</lpage><pub-id pub-id-type="pmid">12077122</pub-id></citation></ref><ref id="pone.0001132-Sada2"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sada</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Siraganian</surname><given-names>RP</given-names></name></person-group><year>2000</year><article-title>Point mutation of a tyrosine in the linker region of Syk results in a gain of function.</article-title><source>J Immunol</source><volume>164</volume><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">10605028</pub-id></citation></ref><ref id="pone.0001132-Fang1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>YC</given-names></name></person-group><year>2001</year><article-title>Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.</article-title><source>Nat Immunol</source><volume>2</volume><fpage>870</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">11526404</pub-id></citation></ref><ref id="pone.0001132-Deckert1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deckert</surname><given-names>M</given-names></name><name><surname>Tartare-Deckert</surname><given-names>S</given-names></name><name><surname>Couture</surname><given-names>C</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name><name><surname>Altman</surname><given-names>A</given-names></name></person-group><year>1996</year><article-title>Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.</article-title><source>Immunity</source><volume>5</volume><fpage>591</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">8986718</pub-id></citation></ref><ref id="pone.0001132-Turner2"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Billadeau</surname><given-names>DD</given-names></name></person-group><year>2002</year><article-title>VAV proteins as signal integrators for multi-subunit immune-recognition receptors.</article-title><source>Nat Rev Immunol</source><volume>2</volume><fpage>476</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">12094222</pub-id></citation></ref><ref id="pone.0001132-Rebecchi1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebecchi</surname><given-names>MJ</given-names></name><name><surname>Pentyala</surname><given-names>SN</given-names></name></person-group><year>2000</year><article-title>Structure, function, and control of phosphoinositide-specific phospholipase C.</article-title><source>Physiol Rev</source><volume>80</volume><fpage>1291</fpage><lpage>1335</lpage><pub-id pub-id-type="pmid">11015615</pub-id></citation></ref><ref id="pone.0001132-Han1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Luby-Phelps</surname><given-names>K</given-names></name><name><surname>Das</surname><given-names>B</given-names></name><name><surname>Shu</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><etal/></person-group><year>1998</year><article-title>Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.</article-title><source>Science</source><volume>279</volume><fpage>558</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">9438848</pub-id></citation></ref><ref id="pone.0001132-Boulven1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boulven</surname><given-names>I</given-names></name><name><surname>Levasseur</surname><given-names>S</given-names></name><name><surname>Marois</surname><given-names>S</given-names></name><name><surname>Pare</surname><given-names>G</given-names></name><name><surname>Rollet-Labelle</surname><given-names>E</given-names></name><etal/></person-group><year>2006</year><article-title>Class IA phosphatidylinositide 3-kinases, rather than p110&#x003b3;, regulate formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis and superoxide production in differentiated neutrophil-like PLB-985 cells.</article-title><source>J Immunol</source><volume>176</volume><fpage>7621</fpage><lpage>7627</lpage><pub-id pub-id-type="pmid">16751409</pub-id></citation></ref><ref id="pone.0001132-Condliffe1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Condliffe</surname><given-names>AM</given-names></name><name><surname>Davidson</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>KE</given-names></name><name><surname>Ellson</surname><given-names>CD</given-names></name><name><surname>Crabbe</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils.</article-title><source>Blood</source><volume>106</volume><fpage>1432</fpage><lpage>1440</lpage><pub-id pub-id-type="pmid">15878979</pub-id></citation></ref><ref id="pone.0001132-Schruefer1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schruefer</surname><given-names>R</given-names></name><name><surname>Sulyok</surname><given-names>S</given-names></name><name><surname>Schymeinsky</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>T</given-names></name><name><surname>Scharffetter-Kochanek</surname><given-names>K</given-names></name><etal/></person-group><year>2006</year><article-title>The proangiogenic capacity of polymorphonuclear neutrophils delineated by microarray technique and by measurement of neovascularization in wounded skin of CD18-deficient mice.</article-title><source>J Vasc Res</source><volume>43</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16227701</pub-id></citation></ref><ref id="pone.0001132-TheilgaardMonch1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theilgaard-Monch</surname><given-names>K</given-names></name><name><surname>Knudsen</surname><given-names>S</given-names></name><name><surname>Follin</surname><given-names>P</given-names></name><name><surname>Borregaard</surname><given-names>N</given-names></name></person-group><year>2004</year><article-title>The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing.</article-title><source>J Immunol</source><volume>172</volume><fpage>7684</fpage><lpage>7693</lpage><pub-id pub-id-type="pmid">15187151</pub-id></citation></ref><ref id="pone.0001132-Chavakis1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chavakis</surname><given-names>E</given-names></name><name><surname>Aicher</surname><given-names>A</given-names></name><name><surname>Heeschen</surname><given-names>C</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Kaiser</surname><given-names>R</given-names></name><etal/></person-group><year>2005</year><article-title>Role of &#x003b2;<sub>2</sub>-integrins for homing and neovascularization capacity of endothelial progenitor cells.</article-title><source>J Exp Med</source><volume>201</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15623573</pub-id></citation></ref><ref id="pone.0001132-Sebzda1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebzda</surname><given-names>E</given-names></name><name><surname>Hibbard</surname><given-names>C</given-names></name><name><surname>Sweeney</surname><given-names>S</given-names></name><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Bezman</surname><given-names>N</given-names></name><etal/></person-group><year>2006</year><article-title>Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development.</article-title><source>Dev Cell</source><volume>11</volume><fpage>349</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">16950126</pub-id></citation></ref><ref id="pone.0001132-Abtahian2"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abtahian</surname><given-names>F</given-names></name><name><surname>Guerriero</surname><given-names>A</given-names></name><name><surname>Sebzda</surname><given-names>E</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><etal/></person-group><year>2003</year><article-title>Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk.</article-title><source>Science</source><volume>299</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">12522250</pub-id></citation></ref><ref id="pone.0001132-Rommel1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rommel</surname><given-names>C</given-names></name><name><surname>Camps</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name></person-group><year>2007</year><article-title>PI3K&#x003b4; and PI3K&#x003b3;: partners in crime in inflammation in rheumatoid arthritis and beyond?</article-title><source>Nat Rev Immunol</source><volume>7</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">17290298</pub-id></citation></ref><ref id="pone.0001132-Lee1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Hayflick</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Puri</surname><given-names>KD</given-names></name></person-group><year>2006</year><article-title>Inhibition of phosphoinositide 3-kinase &#x003b4; attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.</article-title><source>Faseb J</source><volume>20</volume><fpage>455</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">16507763</pub-id></citation></ref><ref id="pone.0001132-Liu1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Puri</surname><given-names>KD</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year>2007</year><article-title>Leukocyte PI3K&#x003b3; and PI3K&#x003b4; have temporally distinct roles for leukocyte recruitment in vivo.</article-title><source>Blood</source><volume>110</volume><fpage>1191</fpage><lpage>1198</lpage><pub-id pub-id-type="pmid">17488877</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>The work has been funded by grants of the Deutsche Forschungsgemeinschaft; Wa 1048/2&#x02013;3 (to B. Walzog) and SFB 497-C7 (to K. Scharffetter-Kochanek).</p></fn></fn-group></back></article> 